Before the markets closed today, Trump signed steel and aluminum import tariff proclamations. Art Hogan is the Chief Market Strategist for B. Riley FBR and Wunderlich Securities. He joins to give his reaction to the new tariffs.
Hogan said markets have been reacting since President Trump announced the possibility of tariffs. For many investors, Hogan said the tariffs felt rushed to market, and that drew a lot of concern regarding potential trade and tariff wars.
When it comes to the new tariffs, Mexico and Canada are indefinitely exempt. These two countries represent a large portion of American trade. The tariff also includes a window of 15 days before it goes into effect. This gives other countries the opportunity to negotiate and manage the tariffs.
Hogan says the best scenario would be no tariffs, but this is is a better tariff than initially expected.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
Two of the top low-cost online retailers are going head to head in a new legal battle. Cheddar News' Michelle Castillo breaks the lawsuit down.
The number of Americans filing for jobless benefits fell last week as the labor market continues to thrive despite high interest rates and elevated costs.
The earliest version of Disney's Mickey Mouse will become public domain on Jan. 1, 2024.
The toy magic oven called the Cookeez Makery is one of the hottest toys for kids this holiday season.
In the UK, IKEA is looking to give away some meatballs, and not just regular-size meatballs.
Dwayne 'The Rock' Johnson is set to star in a movie playing MMA and UFC legend, Mark Care, while Kevin Hart will headline a boxing project over on Peacock.
Coca-Cola is recalling drinks sold in three southern states due to possible "foreign materials" inside cans.
Stocks jumped after the Dow Jones closed at a record high while fresh retail sales data showed positive consumer spending ahead of the holidays.
The Food and Drug Administration is asking Congress for new powers, including the ability to mandate drug recalls and require eyedrop makers to undergo inspections before shipping products to the U.S.
